All In Biotech

Free tool

FAERS Monitor: Penicillin G Potassium In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050638 or its brand name (Penicillin G Potassium In Plastic Container, Penicillin G Potassium). Reports on generic versions are filed under their own applications.

Reports

2,352

Serious

1,747

74% of reports

Hospitalization

821

Death reported

241

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity671
  • drug ineffective342
  • rash244
  • dyspnoea243
  • diarrhoea233
  • nausea214
  • off label use209
  • malaise199
  • drug intolerance192
  • abdominal pain upper180
  • cough161
  • headache157
  • arthralgia150
  • hypersensitivity150
  • anxiety143

Reports by year received

View as table
YearReports
200418
200520
200629
200757
200829
200937
201028
201145
2012140
201329
201424
201528
201640
201760
2018113
2019141
2020155
2021200
2022296
2023316
2024253
2025196
202698

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,807 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal67131.129.219,638
drug intoleranceSignal19217.815.53,037
abdominal pain upperSignal1807.86.81,074
hypersensitivitySignal1507.26.2806
coughSignal1615.14.4539
rashSignal2445.04.4795
anxietySignal1434.53.8390
malaiseSignal1994.13.6465
dyspnoeaSignal2433.83.4521
diarrhoeaSignal2333.22.9367
arthralgiaSignal1503.22.8233
nauseaSignal2142.42.1183
drug ineffectiveSignal3422.32.1273
headacheSignal1572.21.9110
off label useSignal2092.11.9130

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.